This site uses cookies to offer you a better browsing experience.
Learn more
Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Find us in your country
Find us in your country

Latest press releases

Partnering

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Chagas Disease

Click here to learn more about Chagas and how we’re helping to fight it.
Healthy aging

Healthy aging

Bayer at ACC.17

Bayer at ACC.17

Information about Bayer sponsored clinical studies

Bayer Trial Finder

Clinicaltrials.gov

Data Sharing Portal

News

2017-06-23

Bayer Receives Positive CHMP Opinion for regorafenib for the Second-Line Systemic Treatment of Liver Cancer

2017-05-18

Bayer to Highlight Oncology Franchise Research at ASCO 2017

2017-05-17

Bayer Receives FDA Priority Review For Investigational Anti-Cancer Compound Copanlisib

2017-04-28

Rivaroxaban 10 mg Once Daily from Bayer Submitted to U.S. FDA as Additional Dose Option to Reduce the Risk of Recurrent Venous Thromboembolism

2017-04-28

Bayer Receives FDA Approval for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer
Press center